ReviewFrontiers in immunology2024

Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients.

Martina Lorenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.